Disc Medicine Inc’s recent filing unveils that its Director Bitterman Kevin unloaded Company’s shares for reported $68968.0 on Dec 17 ’25. In the deal valued at $91.47 per share,754 shares were sold. As a result of this transaction, Bitterman Kevin now holds 14,013 shares worth roughly $1.11 million.
Then, AI DMI LLC bought 50 shares, generating $4,374 in total proceeds.
Before that, Atlas Venture Fund XII, LP bought 148 shares. Disc Medicine Inc shares valued at $13,538 were divested by the Shareholder at a price of $91.47 per share.
A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating.
Price Performance Review of IRON
On Monday, Disc Medicine Inc [NASDAQ:IRON] saw its stock fall -0.62% to $79.54. Over the last five days, the stock has lost -13.54%. Disc Medicine Inc shares have risen nearly 25.26% since the year began. Nevertheless, the stocks have risen 25.46% over the past one year. While a 52-week high of $99.50 was reached on 12/08/25, a 52-week low of $30.82 was recorded on 04/09/25.
Levels Of Support And Resistance For IRON Stock
The 24-hour chart illustrates a support level at 77.36, which if violated will result in even more drops to 75.19. On the upside, there is a resistance level at 81.60. A further resistance level may holdings at 83.66.
How much short interest is there in Disc Medicine Inc?
A steep rise in short interest was recorded in Disc Medicine Inc stocks on 2025-11-28, dropping by -0.28 million shares to a total of 2.59 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 2.87 million shares. There was a decline of -10.83%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 27, 2025 when TD Cowen began covering the stock and recommended ‘”a Buy”‘ rating.
